MARSHALL WACE, LLP

Position in BCYC — Bicycle Therapeutics PLC

CIK 1318757 LONDON, X0

Position in BCYC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,750,833

+$1,476,166 QoQ

Shares Held

377,335

+872.6% QoQ

Ownership

0.539%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,756,303,735 across 280 Biotechnology names. BCYC ranks #164 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,099,318	$363,731,344
2	VRTX	Vertex Pharmaceuticals Inc / Ma	317,058	$141,579,078
3	INCY	Incyte Corp	1,253,138	$117,945,347
4	RPRX	Royalty Pharma plc	2,120,692	$101,729,594
5	RCUS	Arcus Biosciences, Inc.	3,761,437	$81,247,039
6	PTGX	Protagonist Therapeutics, Inc	628,075	$66,199,104
7	ROIV	Roivant Sciences Ltd.	2,246,943	$62,240,320
8	COGT	Cogent Biosciences, Inc.	1,600,168	$61,590,466

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,750,833	377,335	+872.6%	Shares	Other	2026-05-15
2025-12-31	$274,667	38,795	-88.3%	Shares	Other	2026-02-13
2024-09-30	$7,473,738	330,258	+271.1%	Shares	Other	2024-11-14
2024-06-30	$1,801,096	88,987	+859.8%	Shares	Other	2024-08-14
2023-06-30	$236,595	9,271	-87.9%	Shares	Other	2023-08-14
2023-03-31	$1,630,323	76,649	+726.8%	Shares	Other	2023-05-15
2022-12-31	$274,421	9,271	0.0%	Shares	Other	2023-02-14
2022-09-30	$215,643	9,271	-88.4%	Shares	Other	2022-11-14
2022-06-30	$1,344,463	80,123	+654.5%	Shares	Other	2022-08-15
2022-03-31	$465,961	10,619	-78.9%	Shares	Other	2022-05-16
2021-12-31	$3,067,726	50,398	+555.0%	Shares	Other	2022-02-14
2021-09-30	$319,993	7,694	-64.9%	Shares	Sole	2021-11-15
2021-03-31	$654,660	21,917	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.